10-Q: DocGo Reports Q2 2026 Results Amid Revenue Decline
Quarterly Report
DocGo Inc. reported a net loss of $18.0 million for Q2 2026, with revenues down 8.7% year-over-year, primarily due to the wind-down of migrant-related services.
Summary
- DocGo Inc. reported a net loss of $18.0 million for the three months ended June 30, 2026, a worsening from a $13.3 million net loss in the same period of 2025. For the six months ended June 30, 2026, the net loss was $34.7 million, compared to $24.3 million in the prior year.
- Total revenues for the second quarter of 2026 were $73.4 million, a decrease of 8.7% from $80.4 million in Q2 2025. The six-month revenue also decreased by 15.6% to $149.0 million from $176.5 million.
- The decline in Mobile Health Services revenue was significant, down 30.5% for the quarter and 40.7% for the six months, primarily due to the wind-down of large migrant-related projects.
- Transportation Services revenue saw a modest increase of 4.8% for the quarter to $52.0 million and 3.5% for the six months to $104.0 million, driven by increased trip volumes and average trip prices in the U.S.
- The company is actively discussing its credit facility covenant non-compliance with its lender and exploring alternative financing options, indicating potential liquidity challenges.
- Goodwill and intangible assets were fully impaired as of December 31, 2025, with no remaining carrying value.
- The company received a Nasdaq notice regarding minimum bid price compliance and has been granted an extended period to regain compliance.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as negative due to significant revenue declines, increased net losses, and ongoing liquidity concerns, despite some operational improvements in the transportation segment.
Positives
- Transportation Services revenue increased by 4.8% in Q2 2026 compared to Q2 2025, reaching $52.0 million.
- U.S. trip volumes for Transportation Services increased by 10.8% in Q2 2026, with average trip prices rising to $426 from $410.
- The company is actively pursuing cost-cutting measures, leading to a decrease in corporate operating expenses.
- The company received $4.7 million in insurance proceeds during the first six months of 2026.
Negatives
- Net loss for Q2 2026 was $18.0 million, an increase from $13.3 million in Q2 2025.
- Net loss for the first six months of 2026 was $34.7 million, up from $24.3 million in the same period of 2025.
- Revenues declined by 8.7% in Q2 2026 and 15.6% for the first six months of 2026.
- Mobile Health Services revenue saw a significant decline of 30.5% in Q2 2026 and 40.7% for the first six months, largely due to the wind-down of migrant-related projects.
- Cost of revenues as a percentage of revenues increased to 69.5% in Q2 2026 from 68.4% in Q2 2025.
- Operating expenses as a percentage of revenue increased from 53.4% in Q2 2025 to 54.9% in Q2 2026.
- The company is not in compliance with a minimum liquidity financial covenant under its Credit Agreement and is in active discussions with its lender.
- The company received a Nasdaq notice for non-compliance with the minimum bid price requirement.
Risks
- The company is not in compliance with a minimum liquidity financial covenant under its Credit Agreement and is in active discussions with its lender to reach a resolution.
- The company received a Nasdaq notice for non-compliance with the minimum bid price requirement and has until January 25, 2027, to regain compliance.
- The wind-down of large migrant-related projects has significantly impacted Mobile Health Services revenues, and future revenues from this sector are expected to be insignificant.
- Increased labor costs, including wages and benefits, could adversely affect the company's business if not offset by increased rates.
- The company's reliance on a few large customers for a significant portion of its revenue presents a concentration risk.
- The company's ability to continue as a going concern is subject to the successful implementation of cost-reduction plans and securing necessary financing.
Future Outlook
The company expects overall Mobile Health Services revenues to be lower in 2026 than in 2025 due to the absence of migrant-related project revenues. Transportation Services are expected to continue growing. The company is focused on cost-cutting measures and is actively seeking to resolve its credit facility covenant non-compliance and secure additional financing.
Management Comments
- The decline in revenues was due to the ongoing wind-down of migrant-related services, which had ramped up sharply in the third quarter of 2023 and peaked in the first quarter of 2024.
- As such, despite the Company's expectation for revenue growth in other business lines within the Mobile Health Services segment, we expect that overall Mobile Health Services revenues will be lower in 2026 than they were in 2025, given the absence of migrant-related project revenues.
- Over the remainder of 2026, we expect that general and administrative costs will decline sequentially in both absolute dollars and as a percentage of revenues.
- The Company is actively monitoring the closing bid price of the Common Stock and will evaluate available options to regain compliance with the Minimum Bid Requirement, including initiating a reverse stock split.
Industry Context
StockSavvy.ai notes that the decline in DocGo's Mobile Health Services revenue is largely attributed to the cessation of significant municipal contracts related to migrant services. This highlights the volatility associated with government contracts and the company's need to diversify its revenue streams. The growth in Transportation Services, however, indicates resilience in that segment, driven by increased demand and pricing power in the U.S. market.
Comparison to Industry Standards
- The company's operating loss margin for Q2 2026 was 24.4%, which is significantly higher than the typical profitability expected in the healthcare services sector, suggesting operational inefficiencies or market pressures.
- The increase in cost of revenues as a percentage of revenue (69.5% in Q2 2026 vs. 68.4% in Q2 2025) indicates potential pressure on gross margins, which is a concern in an industry where cost control is crucial for profitability.
- The company's net loss per share of $0.16 for Q2 2026, compared to $0.11 in the prior year, indicates a worsening financial performance on a per-share basis, which is unfavorable compared to industry peers focused on growth and profitability.
Legal Proceedings
- California Labor Actions: Settlement in principle reached for $220,000, with final approval hearing scheduled for August 10, 2026.
- Stockholder Actions: Settlement approved for $12,500,000 (covered by insurance, subject to retention). Derivative actions are ongoing.
- Cybersecurity Action: Settlement finalized and approved for $337,198, covered by cybersecurity insurance.
Related Party Transactions
- Payments to Ely D. Tendler Strategic & Legal Services PLLC for legal services totaling $511,315 for the six months ended June 30, 2026.
- Subcontractor payments to PrideStaff (owned by a former operations manager) were $0 for the six months ended June 30, 2026.
- Consulting fees were paid to Stan Vashovsky during the consulting period ending March 31, 2025.
- No payments were made to Steven Katz under the Katz Consulting Agreement for the six months ended June 30, 2026.
Stakeholder Impact
- Shareholders: Potential dilution from future equity financing, ongoing concerns about Nasdaq listing compliance, and continued net losses impacting stock value.
- Employees: Potential impact from cost-cutting measures, including workforce reductions, and ongoing efforts to manage labor costs.
- Lenders: Concerns regarding covenant non-compliance and ongoing discussions for resolution and potential new financing.
- Customers: Continued provision of Transportation Services, but potential impact on Mobile Health Services due to the wind-down of certain contracts.
Next Steps
- Regain compliance with Nasdaq's minimum bid price requirement.
- Resolve covenant non-compliance with the lender and secure access to the revolving credit facility.
- Implement cost-reduction plans, including transitioning compensation to stock, intensifying collection efforts, reducing headcount, and delaying spending on growth strategies.
- Continue to grow Transportation Services revenue and explore new business lines within Mobile Health Services.
- Monitor and manage labor costs and recruitment efforts.
- Evaluate options to improve liquidity and financial stability.
Key Dates
| Date | Description |
|---|---|
| 2021-11-05 | Completion of business combination and name change to DocGo Inc. |
| 2022-11-01 | Entry into Prior Credit Agreement |
| 2023-03-30 | Filing of California Labor Action (Lowe Action) |
| 2024-03-07 | Separation and consulting agreement with Stan Vashovsky |
| 2024-10-20 | Acquisition of SteadyMD, Inc. |
| 2025-08-07 | Amendment and restatement of Prior Credit Agreement into the Credit Agreement |
| 2026-06-30 | End of the quarterly period covered by the report |
| 2026-08-17 | Filing Date of the Form 10-Q |
Recommendation
sellThe company's worsening financial performance, with increased net losses and declining revenues, coupled with significant liquidity concerns and Nasdaq listing challenges, suggests a negative outlook. While the Transportation Services segment shows some growth, it is overshadowed by the struggles in Mobile Health Services and the overall financial instability.
Keywords
Mobile Health Services, Transportation Services, Revenue Decline, Net Loss, Liquidity, Nasdaq Compliance, Cost Cutting, Migrant Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.